Introduction {#s1}
============

DNA trinucleotide repeats are subject to frequent expansions and contractions in families affected by Huntington\'s disease (HD) and other inherited neurological disorders [@pgen.1001298-Pearson1], [@pgen.1001298-Mirkin1]. Some expanded triplet repeats also cause chromosome fragility, as in fragile X syndrome [@pgen.1001298-Pearson1]--[@pgen.1001298-Freudenreich1]. The complexity of triplet repeat instability in humans makes it likely that multiple mechanisms contribute to the problem. Two major sources of instability have been identified [@pgen.1001298-Pearson1], [@pgen.1001298-Mirkin1], [@pgen.1001298-Kovtun1]. The first is erroneous DNA repair, which can account for instability in both proliferating and non-proliferating cells. Evidence for erroneous repair of triplet repeats includes the finding of fewer expansions of long CAG/CTG alleles in knockout mice deficient in DNA repair factors Msh2, Msh3, Pms2, or Ogg1 (summarized in [@pgen.1001298-Kovtun1]. Less is known in mammals about a causative role of repair on contractions or fragility, although CAG repeat contractions in a human cell line depend on elements of mismatch and nucleotide-excision repair [@pgen.1001298-Lin1]. The second major source of instability is aberrant DNA replication in proliferating cells. Many DNA replication mutants show altered levels of triplet repeat instability [@pgen.1001298-Pearson1], [@pgen.1001298-Mirkin1], and treatment of human cell lines with DNA replication inhibitors affects expansions, contractions, and fragility [@pgen.1001298-Freudenreich1], [@pgen.1001298-Yang1]. Proliferating cells such as those in the male germ line are prone to expansions, although it is not known whether replication is causative in these cells. For example, expansions are present in pre-meiotic testicular germ cells from HD patients, with additional instability in meiotic and post-meiotic cells [@pgen.1001298-Yoon1].

Sister chromatid cohesion is one important facet of DNA metabolism that has not been investigated for an effect on triplet repeat instability. A potential role of SCC in modulating triplet repeats is supported by the interplay of SCC with DNA repair [@pgen.1001298-Strm1], [@pgen.1001298-nal1] and with replication (summarized in [@pgen.1001298-Skibbens1]. One protein complex that participates in SCC is the alternative clamp loader/unloader Ctf18-Dcc1-Ctf8-RFC (Ctf18-RFC). In the absence of the Ctf18-RFC, SCC is compromised [@pgen.1001298-Hanna1], [@pgen.1001298-Mayer1]. Biochemically, Ctf18-RFC can load and unload PCNA onto DNA [@pgen.1001298-Bermudez1]--[@pgen.1001298-Bylund1]. It has been proposed that the PCNA unloading activity of Ctf18-RFC may be important to facilitate passage of the replication fork through the cohesin ring [@pgen.1001298-Bylund1], [@pgen.1001298-Lengronne1]. Ctf18-RFC has also been proposed to play a more general role in fork stabilization [@pgen.1001298-Ansbach1]. The ability of Ctf18-RFC to recruit PCNA to hydroxyurea-stalled replication forks [@pgen.1001298-Lengronne1] and to act together with the checkpoint mediator protein Mrc1 in the DNA replication checkpoint [@pgen.1001298-Crabbe1] is consistent with a more general role at stalled forks.

This paper describes the discovery, through blind mutant screens, of yeast Ctf18-RFC mutants that destabilize triplet repeats. Genetic analysis indicates Ctf18-RFC likely acts through replication fork stabilization and/or post-replication repair (PRR), not SCC, to prevent triplet repeat instability, chromosome fragility and cell cycle delays in S and G2/M phases. Our data also support a general role for the Ctf18-RFC complex in preventing DNA damage, a role which becomes more crucial in the presence of an at-risk sequence such as an expanded trinucleotide repeat tract.

Results {#s2}
=======

Triplet repeat instability is increased in Ctf18-RFC but not SCC mutants {#s2a}
------------------------------------------------------------------------

Two independent genetic screens identified mutants in Ctf18-RFC as defective in stabilization of trinucleotide repeats ([Text S1](#pgen.1001298.s005){ref-type="supplementary-material"}). In screen one, the yeast strain contained a (CAG)~20~-*URA3* reporter to monitor contractions ([Figure S1](#pgen.1001298.s001){ref-type="supplementary-material"}). This strain was transformed with a gene disruption library, and transformants were screened for increased rate of contractions [@pgen.1001298-Razidlo1]. Following three rounds of testing with increasing stringency, vectorette PCR was used to identify a *ctf18::LEU2* allele. The contraction phenotype was confirmed in a commercially obtained *ctf18* strain. In screen two, mutants were sought that increased the rate of fragility for a (CAG)~85~ tract on a yeast artificial chromosome (YAC; [Figure S2](#pgen.1001298.s002){ref-type="supplementary-material"}) [@pgen.1001298-Callahan1]. Transfer of the YAC to the commercial haploid deletion strain set was followed by assays for increased fragility. Several rounds of screening showed that the *dcc1* mutant reproducibly displayed the fragility phenotype. Thus, two different genetic screens for defects in regulating triplet repeat instability converged on the Ctf18 and Dcc1 components of the Ctf18-Dcc1-Ctf8-RFC complex.

Subsequent analysis proved that *ctf18* and *dcc1* mutants exhibited increased levels of trinucleotide repeat contractions, expansions, and fragility. Contractions in these mutants were increased in every case, by up to 8-fold, for a wide range of repeat lengths (short (CAG)~20~, medium (CAG)~70~, and long (CAG)~155~ tracts; [Figure 1A and 1B](#pgen-1001298-g001){ref-type="fig"}; [Table S1](#pgen.1001298.s003){ref-type="supplementary-material"}). In fact, the contraction phenotype of *dcc1* and *ctf18* mutants for long tracts was so pronounced ([Figure 1B](#pgen-1001298-g001){ref-type="fig"}) that the fraction of unaffected cells, only 20--30%, was too low for meaningful analysis of expansions in these strains. Expansions of medium length tracts were increased 10- to 15-fold in *ctf18* and *dcc1* mutants ([Figure 1C](#pgen-1001298-g001){ref-type="fig"}); however, these mutants did not increase expansion rates for very short (CAG)~13~ repeats. Fragility was increased 2- to 3 fold for *dcc1* and *ctf18* mutants even in chromosomes without a repeat tract, but was further increased 3- to 5 fold in the presence of an expanded repeat in a length-dependent manner ([Figure 1D](#pgen-1001298-g001){ref-type="fig"}). In summary, inactivation of Ctf18-RFC substantially increased all three types of instability for CAG runs of 20--155 repeats and also increased general chromosome fragility.

![Contraction, expansion, and fragility phenotypes of SCC mutants.\
For all panels, \* denotes p\<0.05 and \*\* designates p\<0.01 compared to the respective wild type strain. All assays are described in [Table S1](#pgen.1001298.s003){ref-type="supplementary-material"}. (A) Contraction rates of (CAG)~20~ and contraction frequencies of (CAG)~70~, normalized to wild type. (B) Percentage of colonies showing contractions of medium (CAG)~70~ or long (CAG)~155~ tracts. (C) Expansions of (CAG)~70~ tracts, normalized to wild type. (D) Fragility rates with no repeat tract, or with medium (CAG)~70~ or long (CAG)~155~ tracts. Error bars denote ± one standard error of the mean (SEM).](pgen.1001298.g001){#pgen-1001298-g001}

If these triplet repeat phenotypes are due to the sister chromatid cohesion (SCC) activity of Ctf18-RFC, then mutants in other SCC genes should show similar results. *CTF4* and *CHL1* were examined first, as these genes gave the closest match to Ctf18-RFC in a genetic interaction map of protein complexes involved in chromosome biology [@pgen.1001298-Collins1]. Mutants in *CTF4* and *CHL1* both show SCC defects [@pgen.1001298-Xu1]--[@pgen.1001298-Skibbens2]. Biochemically, Ctf4 couples polymerase a to Mcm and the replisome progression complex [@pgen.1001298-Gambus1], [@pgen.1001298-Errico1], while Chl1 is a putative DNA helicase that associates with cohesion establishment factor Eco1 [@pgen.1001298-Skibbens2]. Inactivation of *CTF4* did not affect short contractions, but increases were observed in contractions, expansions and fragility of the medium tract, with magnitudes similar to *dcc1* and *ctf18* mutants ([Figure 1A, 1C, 1D](#pgen-1001298-g001){ref-type="fig"}). In contrast, the *chl1* mutant gave virtually no phenotype in triplet repeat assays ([Figure 1A, 1C, 1D](#pgen-1001298-g001){ref-type="fig"}). Since the *ctf4* phenotype could be due to uncoupling of DNA polymerase α from the replication fork [@pgen.1001298-Gambus1], [@pgen.1001298-Errico1] rather than SCC, the *ctf4* and *chl1* results suggested the possibility of an SCC-independent phenotype of mutants in Ctf18-RFC and Ctf4. Accordingly, assays were performed with *scc1-73* and *scc2-4* temperature-sensitive mutants defective in cohesion maintenance and establishment, respectively. At both permissive (23°) and at semi-permissive (31°) temperatures, *scc1-73* and *scc2-4* strains were indistinguishable from wild type in nearly every triplet repeat assay ([Figure 1A, 1C, 1D](#pgen-1001298-g001){ref-type="fig"}). The lack of a triplet repeat instability phenotype in *scc1-73*, *scc2-4*, and *chl1* strains is in contrast to the clear SCC defect seen in these mutants [@pgen.1001298-Xu1], [@pgen.1001298-Suter1]. While SCC cannot be rigorously excluded due to the essential nature of *SCC1* and *SCC2*, the most likely explanation for the lack of phenotypes in *chl1*, *scc1-73*, and *scc2-4* mutants is that Ctf18-RFC mitigates triplet repeat instability in an SCC-independent manner.

Other alternative RFC complexes do not stabilize CAG repeats to the same extent as Ctf18-RFC {#s2b}
--------------------------------------------------------------------------------------------

In addition to the canonical clamp loader composed of Rfc1 and the core of Rfc2-5, there are three alternative clamp loaders; Ctf18-RFC, Elg1-RFC, and Rad24-RFC. The four clamp loaders have distinct biochemical properties, with Ctf18-RFC uniquely exhibiting efficient PCNA unloading [@pgen.1001298-Bylund1]. Is Ctf18-RFC also distinct in regards to triplet repeat stabilization? The instability profiles of *dcc1*, *elg1*, and *rad24* mutants show distinct patterns ([Figure 2](#pgen-1001298-g002){ref-type="fig"}). Deficiency in *DCC1* increased six of seven types of instability: all forms of contraction, expansion (save for short tracts), and fragility. In contrast, the *elg1* and *rad24* mutants showed elevated instability in only three or two assays, respectively ([Figure 2](#pgen-1001298-g002){ref-type="fig"}). Aside from short tract expansions, the magnitude of *elg1* or *rad24* phenotypes was always weaker than for *dcc1*. Short tract expansions were previously shown [@pgen.1001298-Razidlo1] to be especially sensitive to defects in the DNA damage response, including *rad24*, consistent with the specificity for Rad24 seen in [Figure 2](#pgen-1001298-g002){ref-type="fig"}. We conclude that while all three alternative RFC complexes help stabilize CAG/CTG repeats, Ctf18-RFC has the most potent and wide-ranging impact in our assays. Crabbe et al came to a similar conclusion regarding the predominance of Ctf18-RFC in the DNA replication checkpoint [@pgen.1001298-Crabbe1]. Therefore it remained the focus of this study.

![Triplet repeat phenotypes for mutants in three different alternative RFC complexes.\
Assays, display, and symbols are as in legend to [Figure 1](#pgen-1001298-g001){ref-type="fig"}. (A) Contractions and expansions normalized to wild type. (B) Rates of fragility for strains with no repeat tract, medium (CAG)~70~, or long (CAG)~155~ tracts. Error bars, ±1 SEM.](pgen.1001298.g002){#pgen-1001298-g002}

Repeat instability in the absence of Ctf18-RFC is Rad52-dependent {#s2c}
-----------------------------------------------------------------

Since SCC defects did not account for instability of triplet repeats, we tested the idea that strains deficient for Ctf18-RFC suffer enhanced DNA damage at the trinucleotide repeat, as suggested by the increased repeat fragility in mutants of the complex ([Figure 1](#pgen-1001298-g001){ref-type="fig"}). If so, this damage might be susceptible to *RAD52*-dependent recombinational repair and therefore a *rad52* background should alter the mutational spectrum in the absence of Ctf18-RFC. The results show that mutation of *RAD52* suppressed, partially or completely, every *dcc1* mutability phenotype--contractions of both short and medium CAG/CTG tracts and expansion of medium tracts ([Figure 3A](#pgen-1001298-g003){ref-type="fig"}). We conclude that Rad52-dependent repair in the absence of Ctf18-RFC does not proceed with fidelity in the context of a CAG repeat, since it results in expansions and contractions. A similar result was also observed in *srs2* and *mre11* mutants, where increased levels of medium- and long-tract repeat expansions and contractions were dependent on Rad52 [@pgen.1001298-Kerrest1], [@pgen.1001298-Sundararajan1]. Some medium tract contractions were Rad52-independent ([Figure 3A](#pgen-1001298-g003){ref-type="fig"}); previous data indicated that an additional source of contractions could be processing of DSBs within the repeat tract followed by microhomology-mediated end joining [@pgen.1001298-Sundararajan1]. Fragility was not suppressed or significantly increased in a *dcc1 rad52* double mutant compared to the *dcc1* single mutant ([Figure 3B](#pgen-1001298-g003){ref-type="fig"}), indicating that Rad52 does not contribute to fragility resulting from DNA damage in Ctf18-RFC deficient cells. In summary, in the absence of Ctf18-RFC, a Rad52-dependent pathway is operative that is responsible for the majority of the observed contractions and expansions.

![Analysis of *rad52* effects on triplet repeat instability phenotype of *dcc1*.\
Contractions, expansions, and fragility were measured as described in [Table S1](#pgen.1001298.s003){ref-type="supplementary-material"}. (A) Contraction and expansion phenotypes normalized to wild type. \*, p\<0.05, \*\*, p\<0.01 compared to wild type; ^Δ^, p\<0.05 compared to *dcc1*. (B) Fragility measurements as in [Figure 1](#pgen-1001298-g001){ref-type="fig"}; the *dcc1 rad52* mutant had a (CAG)~65~ repeat. Error bars, ±1 SEM.](pgen.1001298.g003){#pgen-1001298-g003}

Ctf18-RFC and Mrc1 function in separate pathways {#s2d}
------------------------------------------------

We considered the possibility that stabilization of replication forks by Ctf18-RFC explains its effects on triplet repeat mutations and fragility. This model is supported by studies showing Ctf18 localization to hydroxyurea-stalled forks in *S. cerevisiae* [@pgen.1001298-Lengronne1], its association with replication origins in unperturbed *S. pombe* cells [@pgen.1001298-Ansbach1], and its physical association with DNA polymerase ε [@pgen.1001298-Gavin1]. If true, the fork stabilization model predicts that uncoupling DNA pol ε from the replicative helicase with an *mrc1* mutation [@pgen.1001298-Lou1] should exacerbate the triplet repeat phenotype of Ctf18-RFC mutants. Mrc1 is important both for coupling the helicase and polymerase functions at the replication fork, and in signalling during the replication checkpoint and the DNA damage response [@pgen.1001298-Lou1]--[@pgen.1001298-Tourrire1]. We showed that triplet repeat expansions, contractions, and fragility are elevated in *mrc1* mutants [@pgen.1001298-Razidlo1], [@pgen.1001298-Lahiri1], [@pgen.1001298-Freudenreich2]. Also, *mrc1* interacts genetically with *ctf18*, *ctf8*, and *dcc1* [@pgen.1001298-Pan1].

To test *mrc1* effects on triplet repeat instability in the absence of Ctf18-RFC, contraction rates were compared for short CAG tracts in single and double mutants of *mrc1*, *dcc1*, and *ctf18*. The results in [Table 1](#pgen-1001298-t001){ref-type="table"} show 4.1- to 7.1-fold increased contraction rates for single mutants of *mrc1*, *dcc1*, or *ctf18*. The two double mutants gave effects that were significantly greater than additive: 20-fold for *mrc1 dcc1* (p = 0.05) and 16-fold for *mrc1 ctf18* (p = 0.04). This result suggests that Ctf18-RFC and Mrc1 work in parallel to stabilize short repeats. Forward mutation rates at *CAN1* were also significantly greater than additive in the *mrc1 ctf18* double mutants: 23.4-fold over wt compared to 6.5-fold and 2.6-fold for the respective single mutants ([Table 1](#pgen-1001298-t001){ref-type="table"}; p = 0.002), indicating that these proteins act in different pathways in the context of a non-trinucleotide repeat sequence as well. In contrast, Mrc1, Ctf18, Ctf8, and Dcc1 have been proposed to function in the same SCC pathway [@pgen.1001298-Xu1]. This difference is consistent with our earlier conclusion that Ctf18-RFC stabilizes triplet repeats independently of SCC. The *mrc1 dcc1* and *mrc1 ctf18* double mutants could not be assayed with medium and long tracts due to cell lethality.

10.1371/journal.pgen.1001298.t001

###### Double mutant analysis of *mrc1* with *dcc1* and *ctf18*.

![](pgen.1001298.t001){#pgen-1001298-t001-1}

  Genotype                          Contractions of (CAG)~20~ (fold)                                      *CAN1* forward mutation rate (fold)
  -------------- ---------------------------------------------------------------------- ------------------------------------------------------------------------
  wild type                                      \(1\)                                                                   \(1\)
  *mrc1*          7.1[\*](#nt102){ref-type="table-fn"}[a](#nt106){ref-type="table-fn"}                    6.5[\*](#nt102){ref-type="table-fn"}
  *dcc1*                          4.9[\*](#nt102){ref-type="table-fn"}                                    3.6[\*](#nt102){ref-type="table-fn"}
  *mrc1 dcc1*     20[\*](#nt102){ref-type="table-fn"}[Δ](#nt103){ref-type="table-fn"}                                      NT
  *ctf18*                         4.1[\*](#nt102){ref-type="table-fn"}                                    2.6[\*](#nt102){ref-type="table-fn"}
  *mrc1 ctf18*    16[\*](#nt102){ref-type="table-fn"}[†](#nt104){ref-type="table-fn"}    23.4[\*](#nt102){ref-type="table-fn"}[††](#nt105){ref-type="table-fn"}
  *rad27*                                          NT                                                    33.9[\*](#nt102){ref-type="table-fn"}

Contractions and *CAN1* forward mutations were measured as described in Supplementary information. The wild type rate for contractions was 1.4×10^−7^ per generation. For *CAN1* mutations, the wild type rate was 7.5×10^−7^ per generation. Data for *rad27* are included as a positive control.

**\***p\<0.05 compared to wild type.

**Δ:** p\<0.05 versus *mrc1* and *dcc1* single mutants.

**†:** p\<0.05,

**††:** , p\<0.01, versus *mrc1* and *ctf18* single mutants.

**^a^**contraction rate data from [@pgen.1001298-Razidlo1]. NT, not tested.

Ctf18-RFC--deficient cells exhibit S phase delays and G2/M arrests with a multi-budded morphology, phenotypes exacerbated by the presence of a repeat tract {#s2e}
-----------------------------------------------------------------------------------------------------------------------------------------------------------

The results above suggested that Ctf18-RFC helps cope with triplet repeat-associated damage and in stabilizing replication forks, so we tested directly whether the Ctf18-RFC complex has a role in progression through the cell cycle. Cells from a log phase liquid culture were plated on solid media, and microscopic analysis was used to monitor the proportion of cells in each phase of the cell cycle: unbudded (G1), small budded (bud size one-third or less the size of the mother cell (S), and large budded (G2/M). The results are quantified in [Figure 4A](#pgen-1001298-g004){ref-type="fig"}, and representative micrographs are shown in [Figure 4B](#pgen-1001298-g004){ref-type="fig"}. In wild-type cells with no CAG/CTG tract, there was a distribution of 30% unbudded, 12% small budded, and 55% large budded ([Figure 4A](#pgen-1001298-g004){ref-type="fig"}). The presence of a CAG/CTG tract changed this distribution in two ways. First, there were more small budded (S phase) cells, consistent with replication stress. Second, a new category of cells was observed that were either swollen with large buds or contained multiple buds ([Figure 4B](#pgen-1001298-g004){ref-type="fig"}), a phenotype that is indicative of unresolved damage in G2/M [@pgen.1001298-Enserink1]. The proportion of the multi-budded/swollen cells rose with increasing repeat tract length to as much as 20% of the wild type population ([Figure 4A](#pgen-1001298-g004){ref-type="fig"}). In general the swelling was modest and most multi-budded clusters contained only one extra bud in wild-type cells ([Figure 4B](#pgen-1001298-g004){ref-type="fig"}). In *dcc1* and *ctf18* cells, even without a repeat, multi-budded/swollen cells comprised 18--30% of the population, a level significantly greater than wild-type cells with no tract ([Figure 4A](#pgen-1001298-g004){ref-type="fig"}). This indicates that the absence of the Ctf18-RFC complex leads to some level of repeat-independent damage that causes accumulation of cells in G2/M. Even more strikingly, the combination of an expanded repeat plus the lack of a functional Ctf18-RFC led to an increase in the multi-budded category to 42--54% of cells ([Figure 4B](#pgen-1001298-g004){ref-type="fig"}). In addition, the morphological defects in *dcc1* and *ctf18* mutants with a repeat tract often showed a more severe phenotype, with extreme swelling and many connected buds ([Figure 4B](#pgen-1001298-g004){ref-type="fig"}). Staining of nuclei revealed that some of the cells within multibudded clusters, often the more swollen ones, had fragmented or missing DNA (example in [Figure 6A](#pgen-1001298-g006){ref-type="fig"}). We conclude that Ctf18-RFC has an important function in helping resolve repeat-independent DNA damage, and that damage is persisting into the G2 or M phase. Since this phenotype is enhanced by an expanded triplet repeat, and since the expanded repeat causes replication stress, we also infer that Ctf18-RFC helps cope with repeat-induced replication stress during S phase.

![Cell cycle distribution and morphological abnormalities of *dcc1 and ctf18* mutants.\
(A) Quantification of cell morphology in log phase cultures. Several hundred cells (range 227--723) were scored for each genotype. Note that the *dcc1Δ* long tract was a mixture of cells with 155 repeats and contracted tracts by the end of the experiment; we were not able to complete a *ctf18* long tract experiment without substantial contractions. Differences in the percentage of multi-budded cells were analyzed by a pooled variance t test using the Systat program; \*, p\<0.05, \*\*, p\<0.01 compared to wild type of the same tract length; ^∧^, p\<0.05 compared to the no tract control of the same strain (e.g. p = 0.054 for *dcc1*-70 compared to *dcc1* no tract, and p = 0.013 for *ctf18*-70 compared to ctf18 no tract). (B) Microscopic images of cells; all images are at the same scale, *dcc1* and *ctf18* mutants are characterized by an increase in cell size and the formation of protruded and multiple buds. Dotted lines indicate an overlay of another image to provide additional examples of cells of that genotype.](pgen.1001298.g004){#pgen-1001298-g004}

To measure cell cycle dynamics with more precision, we isolated unbudded G1 cells by micromanipulation and followed their progression through 2--3 cell cycles by microscopy. This single-cell approach measures the time spent in each phase of the cell cycle, and therefore it allows assignment of the cell cycle stage in which defects can first be detected. A schematic example of the approach and some representative data are shown in [Figure 5A](#pgen-1001298-g005){ref-type="fig"}. The majority of wild type cells with no repeat spent ∼30 min in S phase, with a slight shift to longer S phases when a medium-length (CAG)~70~ repeat was present ([Figure 5B](#pgen-1001298-g005){ref-type="fig"}). Cells containing a (CAG)~70~ tract and lacking *DCC1* or *CTF18* exhibited several cell cycle phenotypes. First, they divided much more slowly. Average division time was 5.8 h for *dcc1* (range 2.5--8.5 h) and 3.5 h for *ctf18* (range 2.0--6.0 h), compared to 2.0 h for wild type (CAG)~70~ strain. The presence of the repeats enhanced the delay as the *dcc1* and *ctf18* mutants with no repeat averaged 2.5 h and 2.0 h per division, respectively. Second, some *ctf18* and *dcc1* cells stayed small budded 1--2 h, consistent with an S-phase delay, a phenotype that was exacerbated by the presence of the repeat ([Figure 5B](#pgen-1001298-g005){ref-type="fig"}). In contrast, all wild type cells completed S phase in 1 h or less, regardless of whether the repeat tract was present. Thus, single-cell analysis provides additional evidence for a role of Ctf18-RFC during S phase, as its absence leads to an extended S phase in some cells.

![Single cell analysis of cell cycle dynamics.\
Aliquots from mid-logarithmic phase liquid cultures were plated onto solid media. Single unbudded cells were isolated by micromanipulation, and their progression was monitored by microscopy every 30 min for 6.0--8.5 h (1--4 cell divisions). (A) Examples of how cells were followed and scored. (B) Time spent in each phase of the cell cycle, as scored by budding index (see Materials and [Methods](#s4){ref-type="sec"}). Red bars, S phase; green bars, G2 phase; blue bars, G2+G1 phases.](pgen.1001298.g005){#pgen-1001298-g005}

Effects in G2/M were also evident from the single-cell analysis ([Figure 5B](#pgen-1001298-g005){ref-type="fig"}). All wild type cells had a G2/M phase of 2 h or less, regardless of the presence of the trinucleotide repeat. In contrast, some *dcc1* and *ctf18* cells were detected with G2/M phases of 2 hours or more, even when no repeat was present. The length of the *dcc1* and *ctf18* strain G2/M phase was greatly increased in the presence of the (CAG)~70~ repeat, with some cells remaining in G2/M up to 6--8 h (after which time yeast cells are able to adapt to DNA damage and continue through M even without repair [@pgen.1001298-Sandell1], [@pgen.1001298-Toczyski1]). This single-cell analysis also proved that arrested G2/M cells gave rise to the multi-budded cells described earlier. Finally, when the fate of the colony growth beyond 8 h was monitored, we observed that a majority of the *dcc1* and *ctf18* cells containing the (CAG)~70~ repeat tract only accomplished a few additional cell divisions and did not form colonies visible by eye. This observation indicates that we likely underestimated the fragility and instability phenotypes obtained for (CAG)~70~ repeats, and presumably for (CAG)~155~ repeats.

Elevated levels of DNA damage are generated during S phase and persist into G2/M phase in *ctf18* cells {#s2f}
-------------------------------------------------------------------------------------------------------

The cell cycle delays, increased fragility, and Rad52-dependent instability all suggested that DNA damage may be occurring at CAG repeats in the absence of Ctf18-RFC. To directly test for damage, we measured the proportion of wild type and *ctf18* cells with a Rad52 focus in the presence or absence of CAG repeats ([Figure 6](#pgen-1001298-g006){ref-type="fig"}). Rad52 focus formation occurs at DSBs or at broken replication forks, but not at forks stalled by HU [@pgen.1001298-Lisby1]. In the absence of any repeat, only 1.1% of wild type cells had a Rad52-YFP focus ([Figure 6A and 6B](#pgen-1001298-g006){ref-type="fig"}). The presence of the repeats significantly increased the frequency of Rad52 foci to 3.3% and 3.8% for (CAG)~70~ and (CAG)~155~, respectively ([Figure 6B](#pgen-1001298-g006){ref-type="fig"}). In *ctf18* cells without a repeat tract, the incidence of Rad52 foci was elevated to 8% ([Figure 6B](#pgen-1001298-g006){ref-type="fig"}), indicating that significant levels of DNA damage are occurring in this background, consistent with the increased fragility observed above. In addition, there was a further increase in cells with foci in *ctf18* cells with an expanded repeat, to 17% for both (CAG)~70~ and (CAG)~155~ ([Figure 6B](#pgen-1001298-g006){ref-type="fig"}). Considering that the repeat is in single copy, these data suggest a significant level of damage occurring at the repeat when the Ctf18-RFC complex is not functional.

![Cell cycle dependency of Rad52 focus formation in *ctf18* cells.\
(A) Cultures of wild type and *ctf18* cells were grown to mid-log phase before mounting on a microscope slide. The panel shows differential interference contrast (DIC), DAPI-stained DNA, and Rad52-yellow fluorescent protein (Rad52-YFP) images of selected cells among WT and *ctf18* cells with no tract (−) or with a medium (CAG)~70~ tract (M). Scale bar is 10 µm. (B) Quantification of Rad52 foci formation in WT or *ctf18* cells with no tract (−), medium (CAG)~70~ tract (M) or long (CAG)~155~ tract (L). \*, p\<0.05, \*\*, p\<0.01 compared to wild type of same tract length; ^∧^, p\<0.05, ^∧∧^, p\<0.01 compared to no tract of the same strain. (C) Cell cycle distribution of Rad52 foci. The occurrence of Rad52 foci in G1, S or G2 cells was determined after incubation with α-factor, 40 min after release from G1 or nocodazole, respectively (see [Methods](#s4){ref-type="sec"} for details). Representative examples of *ctf18* cells with medium (CAG)~70~ tract in S or G2 are shown as DIC images (top) or Rad52-YFP foci (bottom). (D) Quantification of Rad52 foci in G1, S, or G2 cell cycle stage. Labels and statistical analysis are as in (B). Percentages obtained for WT cells treated with α-factor are indicated. See [Table S2](#pgen.1001298.s004){ref-type="supplementary-material"} for complete set of data.](pgen.1001298.g006){#pgen-1001298-g006}

To determine when in the cell cycle the damage occurs, we visualized foci in cells at different stages ([Figure 6C and 6D](#pgen-1001298-g006){ref-type="fig"}). In wild type cells without a repeat, foci levels were very low, less than 2%, at all stages ([Figure 6D](#pgen-1001298-g006){ref-type="fig"}). Interestingly, wild type cells containing an expanded CAG repeat had a detectable increase in Rad52 foci in S phase, 40 min after release from α-factor ([Figure 6D](#pgen-1001298-g006){ref-type="fig"}). This timing coincides with replication through the repeat (assessed by 2D gel electrophoresis; R. Anand and C. Freudenreich, data not shown) indicating that Rad52-dependent events at the repeat may be replication-associated. The lower level of foci in cells arrested by nocodazole ([Figure 6D](#pgen-1001298-g006){ref-type="fig"}) suggests that the DNA damage induced in S is usually repaired by G2/M in wild type cells.

In *ctf18* cells, the percentage of Rad52 foci was very low in G1 cells arrested by α-factor, suggesting that the complex does not have a genome protective function in G1 ([Figure 6D](#pgen-1001298-g006){ref-type="fig"}). In contrast, the proportion of cells with a Rad52 focus rose to 24% in S phase, and this number was dramatically increased in the presence of a repeat, to 65% for (CAG)~70~ or 42% for (CAG)~155~ (which was a mixture of 155 and contracted tracts). These data show that Ctf18-RFC has an important S phase role. We also observed *ctf18* S phase cells with more than one Rad52 focus ([Figure 6C](#pgen-1001298-g006){ref-type="fig"}). Contrary to the wild type situation, Rad52 foci frequently persisted into G2/M. 15--30% of the *ctf18* cells still showed Rad52 foci when arrested in G2/early M by nocodazole ([Figure 6D](#pgen-1001298-g006){ref-type="fig"}). DAPI staining revealed that these foci were detectable in both G2 cells with nuclei at the bud neck as well as in cells entering M phase. Thus the repeat-induced damage sometimes persisted into M phase.

Altogether, cell cycle analysis ([Figure 4](#pgen-1001298-g004){ref-type="fig"}, [Figure 5](#pgen-1001298-g005){ref-type="fig"}, [Figure 6](#pgen-1001298-g006){ref-type="fig"}) indicates that damage at the repeat tract likely initiates in S phase, and that presence of Ctf18-RFC is important for completing S phase without delay and without accumulation of DNA damage. Judging by the accumulation of cells and presence of Rad52 foci in G2 and even into M phase, a significant portion of damage persists beyond S phase in Ctf18-RFC deficient cells.

Discussion {#s3}
==========

This work provides evidence for new functions of Ctf18-RFC in preserving genomic integrity, outside its role in sister chromatid cohesion (SCC). These discoveries stemmed from the application of sensitive and specific genetic assays that revealed Ctf18-RFC\'s role in protecting a broad range of CAG/CTG repeat lengths from expansion, contraction, and fragility ([Figure 1](#pgen-1001298-g001){ref-type="fig"}). Ctf18-RFC mutant phenotypes at triplet repeats were distinct from those shown by mutants in other SCC factors, such as *chl1*, *scc1-73*, *scc2-4*, and *mrc1* ([Figure 1](#pgen-1001298-g001){ref-type="fig"}, [Table 1](#pgen-1001298-t001){ref-type="table"}). Ctf18-RFC also was more important at trinucleotide repeats compared to the alternative RFC complexes Elg1-RFC or Rad24-RFC ([Figure 2](#pgen-1001298-g002){ref-type="fig"}). A novel role for Ctf18-RFC in replication fork bypass of lesions that arise from triplet repeats was suggested by analysis of double mutants between Ctf18-RFC and either Mrc1 ([Table 1](#pgen-1001298-t001){ref-type="table"}) or Rad52 ([Figure 3](#pgen-1001298-g003){ref-type="fig"}). In agreement with the idea of a role at the replication fork, cells defective in Ctf18-RFC show an extended S phase and increased S-phase levels of Rad52 foci even in the absence of a triplet repeat ([Figure 5](#pgen-1001298-g005){ref-type="fig"}, [Figure 6](#pgen-1001298-g006){ref-type="fig"}). These mutants also accumulate in G2/M, often with altered morphology and persistence of Rad52 foci ([Figure 4](#pgen-1001298-g004){ref-type="fig"}, [Figure 5](#pgen-1001298-g005){ref-type="fig"}, [Figure 6](#pgen-1001298-g006){ref-type="fig"}), a phenotype consistent with unresolved DNA damage in G2 [@pgen.1001298-Schmidt1]. These altered cell cycle phenotypes occur even in the absence of a triplet repeat, but the presence of an expanded repeat tract severely exacerbated the mutant defects. Taken together, the results of this study suggest that Ctf18-RFC helps avoid DNA damage arising during replication, that Ctf18-RFC may also be important in coping with damage when it persists into G2, and that triplet repeats make budding yeast especially dependent on Ctf18-RFC.

Our observations are consistent with action of Ctf18-RFC in S phase, during or soon after passage of the replication fork. Previous work localized Ctf18 at or near hydroxyurea-stalled forks by Chromatin IP in *S. cerevisiae* [@pgen.1001298-Lengronne1], and to replication origins in unperturbed *S. pombe* cells [@pgen.1001298-Ansbach1]. It was recently shown by DNA combing that fork speed is slowed 3-fold in *ctf18* mutant cells [@pgen.1001298-Crabbe1]. Ctf18-RFC shows a physical association with DNA polymerase ε [@pgen.1001298-Gavin1], [@pgen.1001298-Murakami1], suggesting that it could act directly at the fork in a fork stabilization role. Although our results do not support a role for Ctf18-RFC in cohesion establishment, they are compatible with a role in facilitating replication through the cohesion ring, as proposed in [@pgen.1001298-Bylund1], [@pgen.1001298-Lengronne1]. One way to explain the repeat-specific effects we see is if Ctf18-RFC promotes dis-assembling or re-assembling the replisome to facilitate bypass through replication barriers, such as a cohesin ring or a hairpin structure. Another possibility is Ctf18-RFC could have a more general fork stabilizing function to prevent formation of hairpins or other aberrant secondary structures associated with trinucleotide repeats. In either case, fork integrity would be affected in *ctf18*, *dcc1*, or *ctf8* mutants, leading to fragility and increased recombination, and ultimately to triplet repeat mutations. This model would also explain the *ctf4* phenotype on instability ([Figure 1](#pgen-1001298-g001){ref-type="fig"}), based on the role of Ctf4 in coupling DNA polymerase α to the replication fork [@pgen.1001298-Gambus1], [@pgen.1001298-Errico1]. Alternatively, the Ctf18-RFC S-phase role could be in a repair process that occurs behind the fork, but still in S phase, as described below.

The striking G2/M accumulation phenotype and persistence of Rad52 foci was unexpected in mutants of Ctf18-RFC, in part because this phenotype suggests the presence of unresolved DNA damage that persists beyond S phase. Thus, either the damage incurred during S phase in *ctf18* cells is often not easily repaired, or Ctf18-RFC also plays a role in helping resolve or repair damage during G2. Recently, it was shown that post-replication gap repair can operate effectively when limited to the G2 phase, and the authors proposed that PRR occurs primarily on gaps left behind replication forks that have re-primed and continued [@pgen.1001298-Karras1], [@pgen.1001298-Daigaku1]. Interestingly, their data suggest that error-free PRR, which is dependent on Rad5-catalyzed polyubiquitylation of PCNA, usually commences in S-phase and continues into G2/M. Thus with regard to timing, our data would be consistent with a role for Ctf18-RFC in error-free PRR. The dependence on HR for instability is also consistent with a role in error-free PRR, since strand invasion is needed for the template-switching step. In contrast, it is unlikely that our results with Ctf-18 RFC relate to error-prone PRR, since HR does not occur during translesion synthesis. Notably, the triplet repeat defects associated with absence of Ctf18-RFC are different than results when the PRR pathway is abolished by deletion of Rad5 or abolishing PCNA modification, as those mutants specifically increased expansions, but not contractions, of short repeats [@pgen.1001298-Daee1]. Thus, our results would be most consistent with aberrant PRR, rather than ablation of the pathway.

How might Ctf18-RFC function biochemically to protect triplet repeats? Ctf18-RFC was shown to load and unload PCNA *in vitro* in a manner that is more efficient on single stranded DNA and inhibited by RPA [@pgen.1001298-Bylund1]. Significant unloading was not seen for the other complexes, RFC, Rad24-RFC, and Elg1-RFC. This unique biochemical activity of Ctf18-RFC mirrors the distinct pattern in our genetic observations ([Figure 2](#pgen-1001298-g002){ref-type="fig"}). Possibly the loading/unloading function is especially important at triplet repeats either to bypass a previously formed hairpin structure or to minimize exposed single strands during replication and thereby reduce secondary structure formation and instability. A second possibility is that a defect in PCNA unloading during a gap repair event could lead to a persistent HR structure that would be prone to breakage or cleavage. In this model, contractions could occur during DSB repair end processing as proposed in [@pgen.1001298-Sundararajan1]. In contrast, timely unloading of PCNA could facilitate proper resolution of a recombination intermediate without breakage, for example by Sgs1 dissolution. Sgs1 has a role in resolution of X-shaped SCJs that form upon replication of damaged templates [@pgen.1001298-Branzei1], and a recent study links Sgs1 to resolution of an intermediate that occurs during ubiquitylated PCNA-dependent gap repair [@pgen.1001298-Karras1]. Intriguingly, deletion of *SGS1* also led to increased contractions and fragility, similar to (though not as dramatic as) *ctf18* or *dcc1* mutants, and in some contexts, the contractions were also Rad52-dependent [@pgen.1001298-Kerrest1]. Thus, for example, a defect in Ctf18-dependent unloading of ubiquitylated PCNA could lead to toxic recombination products, similar to a defect in Sgs1 activity. It will be interesting to learn how Ctf18-RFC functions on ubiquitylated PCNA, as we showed previously that expansion rates are elevated when PCNA ubiquitylation is blocked [@pgen.1001298-Daee1].

Does repeat stabilization by Ctf18-RFC extend to human cells? Human Ctf18-RFC was shown to control the velocity, spacing, and restart activity of replication forks via acetylation of the cohesin ring [@pgen.1001298-Terret1]. Also, human Ctf18-RFC has been recently shown to be necessary for accumulation of polymerase ε during repair of UV lesions induced outside of S phase [@pgen.1001298-Ogi1]. A key future study is to see whether, and how, human Ctf18-RFC protects triplet repeats.

Methods {#s4}
=======

Most strains were derived from BY4741 (MATa *his3Δ1 leu2Δ0 met15Δ0 ura3Δ0*) or BY4705 (MATα *his3Δ200 leu2Δ0 lys2Δ0 met15Δ0 trp1Δ63 ura3Δ0*), isogenic derivatives of *Saccharomyces cerevisiae* strain S288C (Open Biosystems; [@pgen.1001298-Brachmann1]. Isogenic derivatives were obtained commercially (Open Biosystems) or were created by targeted deletion of BY4741 or BY4705. The *scc1-73*, *scc2-4* and wild type parent strains (MATa *ade2-1 can1-100 leu2-3,112 his3-11,15 ura3-1 trp1-1*, except *scc1-73* strain that was *TRP1*) were provided by Philippe Pasero, CNRS, Montpellier, France. Strains used for foci experiments were derived from W303 (*MATa ADE2 his3-11,15 leu2-3,112 bar1::LEU2 trp1-1 RAD52-YFP*), obtained from R. Rothstein, Columbia University, NYC, NY. The triplet repeat sequences reported here all have the CAG repeat on the lagging strand template, and CTG repeats on the Okazaki fragment. This CAG nomenclature is used throughout.

Contraction and expansion rates for short CAG tracts were measured by fluctuation analysis, and authenticated by PCR, as previously described [@pgen.1001298-Razidlo1]. Statistical analyses were performed using the Wilcoxon Mann Whitney test. P values of less than 0.05 were considered statistically significant. Forward mutation rates for the *CAN1* gene were determined by fluctuation analysis using canavanine at 60 µg/ml, and statistical analysis was performed using Student\'s t-test for comparison with wt and a two-way ANOVA with interaction tests [@pgen.1001298-Slinker1] for comparison between single and double mutants.

Expansions, contractions, and fragility of medium and long CAG tracts were measured using a YAC system, as described previously [@pgen.1001298-Callahan1]. Diagrams of these assays are shown in [Figure S2](#pgen.1001298.s002){ref-type="supplementary-material"}. Contraction and expansion frequencies for medium (CAG)~70~ and long (CAG)~155~ tracts were determined as previously described previously [@pgen.1001298-Sundararajan1]. For each strain, approximately 150 colonies were analyzed for CAG repeat length by colony PCR in at least three separate experiments, using primers flanking the CAG repeat (P1 and P2 in [Figure S2](#pgen.1001298.s002){ref-type="supplementary-material"}). PCR products were separated on a 2% Metaphor gel (Cambrex Bio Science Rockland, Inc.) and sized. The frequency of repeat expansions and contractions in each strain background was calculated and statistical significance determined by the Fisher\'s exact test. Repeat lengths from 0 to ∼200 CAG repeats with an accuracy of +/−3 repeats can be obtained by this method.

Fragility assays were performed as in [@pgen.1001298-Sundararajan1]. Mutation rate was determined using the method of maximum likelihood [@pgen.1001298-Zheng1] and data presented are an average of 3--5 experiments. Error bars indicate the standard error of the mean. Significance compared to the wild-type value for the same tract length was determined using a pooled variance t-test. Growth temperature was 30°C unless otherwise indicated. A summary of the whole instability and fragility data is represented in the [Table S1](#pgen.1001298.s003){ref-type="supplementary-material"}.

Cell cycle distribution and cell morphologies ([Figure 4](#pgen-1001298-g004){ref-type="fig"}) were obtained as follows: YC-Leu-Ura liquid cultures were grown to mid-logarithmic phase and analyzed microscopically for the presence of unbudded cells, small-budded cells (bud smaller than one-third of the mother cell), large-budded cells (bud equal to or larger than one-third of the mother cell), and other cells (malformed cells with protruded or multiple buds). The assays were repeated at least 3 times for each strain. Pictures of the cells were taken using a Zeiss AX10 microscope, under 63× magnification. Single cell assays ([Figure 5](#pgen-1001298-g005){ref-type="fig"}) were initiated by plating mid-logarithmic phase liquid cultures onto solid YC-Leu-Ura media. Single unbudded cells were isolated by micromanipulation, and their progression was monitored by microscopy every 30 min for 6.0--8.5 h. (1--4 cell divisions). The numbers of single cell lineages monitored were: wild type, no repeat (12); wild type, medium tract (12); *ctf18Δ*, no repeat (24); *ctf18Δ*, medium tract (24); *dcc1Δ*, no repeat (53); and *dcc1Δ*, medium tract (33). Because we did not micromanipulate daughter cells away from each other, and because many of them in fact could not be separated (indicating incomplete cell division and leading to a multi-budded cell), it was not always possible to distinguish the end of G2/M and beginning of G1. In these cases, we grouped the two cell cycle phases (G2+G1). At the end of the experiment, cells still in G2 phase for a time less than the wild-type G2/M average time (1 h for no tract and 1.5 h for medium tract, respectively) were not considered to be informative for their G2 phase, and were not counted.

Cell imaging and fluorescent microscopy: examination of Rad52-YFP focus levels by microscopy was performed as previously described [@pgen.1001298-Lisby2]. Briefly, cells were grown overnight in SC-Leu-Ura media at 23°C and exponentially growing cultures were prepared for microscopy. To visualize nuclear DNA by DAPI staining (50 ng/ml), cells were fixed in ethanol before mounting on the slide. Cell images were captured using a Zeiss AX10 microscope (Carl Zeiss, Thornwood, NY) equipped with a Retiga EXi camera (Qimaging), and acquired using SlideBook software (Intelligent Imaging Innovations, Denver, CO). All images were taken at 63-fold magnification. A single DIC image and 17 YFP images obtained at 0.3-µm intervals along the *z*-axis were captured for each frame, and Rad52-YFP foci were counted by inspecting all focal planes intersecting each cell. For each strain, ∼200--800 cells (range 172--1483; [Table S2](#pgen.1001298.s004){ref-type="supplementary-material"}) were scored for Rad52-YFP foci. Fisher\'s exact t-test was used to calculate significance.

For cell synchronization, cells were arrested in G1 phase by treatment with α-mating factor (3.4 µg/ml; Sigma, St. Louis, MO) for 2--5 hrs (2 for wt, 5 for *ctf18*). S phase was evaluated by releasing cells from G1 arrest by washing three times in water, resuspension in SC-Leu-Ura medium, and 40 min incubation (consistent with replication timing of the CAG repeat on the yeast artificial chromosome, R. Anand and C. H. Freudenreich, unpublished results) prior to processing for fluorescence microscopy. Prolonged time in the presence of α-mating factor didn\'t eliminate the multi-budded category; *ctf18* multi-budded clusters were excluded from the G1 and S phase Rad52 foci quantification. For G2/M arrest, cells were treated with 0.2 M nocodazole for 3--5 hrs. Because of the high frequency of multi-budded cells in the *ctf18* strain, DNA DAPI staining was used as the reference to set the total number of cells.
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A genetic assay to monitor short trinucleotide repeat (TNR) contractions and expansions in yeast. The regulatory region controlling expression of the reporter gene *URA3* is shown. Important features include the TATA box, the trinucleotide region, an out-of-frame initiator codon (in red), the preferred transcription initiation site "I", and the start of the *URA3* gene with initiator ATG codon in green. Anticipated transcription is shown as the right-angle arrow. For both panels, the top strand (i.e., the sense strand of *URA3*) is the lagging strand template. (A) Yeast cells that have undergone a TNR contraction can be selected by their ability to grow in the absence of uracil. The starting strain is Ura^−^ due to the inserted triplet repeat sequence, (CNG)~20+13~. (This nomenclature refers to 20 repeats of the trinucleotide CNG, where N = any nucleotide, plus 39 bp of randomized, genetically inert sequence (Dixon and Lahue, 2004). The total DNA length is therefore equivalent to 33 repeats.) Insertion of this many nucleotides between the TATA box and the preferred transcription initiation site places "I" too far from the TATA box, such that transcription is predicted to begin upstream. This incorporates an out-of-frame ATG (red), resulting in translational incompetence (indicated by X) and leading to a non-functional *URA3* product. Cells have a Ura^−^ phenotype. If a contraction occurs, losing 5 to 20 repeats, initiation will occur at the proper site "I," leading to expression of *URA3* and attainment of the Ura^+^ phenotype. (B) Yeast that have undergone an expansion can be identified by growth in the presence of 5FOA. (CNG)~13+12~ refers to 13 repeats of the trinucleotide CNG plus 36 bp of randomized sequence (Rolfsmeier *et al*, 2001). The total DNA length is equivalent to 25 repeats. Proper initiation at "I" results in functional expression of *URA3*, which confers sensitivity to the drug 5-fluoroorotic acid (5FOA). If the TNR expands, gaining 5 or more repeats, upstream transcription initiation will include the red out-of-frame ATG, resulting in translational incompetence and resistance to 5FOA.
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Genetic assays for contractions, expansions, and fragility of medium and long CAG repeat tracts. Structure of the YAC containing CAG/CTG repeats (written as CAG; CAG on the top strand), described in (Callahan *et al*, 2003; Sundararajan *et al*, 2010). The CAG/CTG repeats on the YAC are oriented such that the CAG strand is on the lagging strand template while the CTG strand is on the leading strand template, an orientation where the repeats are less prone to contractions. Cells containing the full-length YAC are Leu^+^ and FOA^S^. Breakage at the CAG tract and healing at the G~4~T~4~/C~4~A~4~ telomere seed results in Leu^+^ FOA^R^ colonies. P1 and P2 indicate the location of primers used to amplify the CAG tract to assay tract length by PCR.
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Contractions, expansions, fragility.
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Foci formation.
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